Home > Products > Chemicals > Pharmaceutical Chemicals

Product Name:LGD-4033(Ligandrol)
Other Name:Ligandrol
CAS:1165910-22-4
MF:C14H12F6N2O
MW:338.2482992
EINCES:1806241-263-5
Appearance:white powder
Purity:99.% min
Package:10g,100g,500g and 1kg or as customers'request.
Test Method:HPLC
Min Order:Powder---10gram
Payment:Bitcoin,Moneygram and Wester Union
Lead time:24hours after received payment
Safe shipping to US and most of Europe country

What is LGD-4033?
LGD-4033 is a selective androgen receptor modulator (SARMS), and a novel non-steroidal oral SARM that binds to AR with high affinity (Ki of ~1 nM) and selectivity. It's in a class of androgen receptor (AR) ligands that is tissue selective, developed to treat muscle wasting associated with cancer, acute and chronic illness and age-related muscle loss. LGD-4033 is expected to produce the therapeutic benefits of testosterone with improved safety, tolerability and patient acceptance due to tissue-selective mechanism of action and an oral route of administration.

Benefit:
Ligandrol 4033 is a selective androgen receptor modulator (SARMS), and a novel non-steroidal SARM that binds to AR with high affinity (Ki of ~1 nM) and selectivity. It's in a class of androgen receptor (AR) ligands that is tissue selective, developed to treat muscle wasting associated with cancer, acute and chronic illness and age-related muscle loss. LGD-4033 is expected to produce the therapeutic benefits of tolerability and patient acceptance due to tissue-selective mechanism of action and an route of administration.

How it works?
LGD-4033, a novel nonsteroidal, oral selective androgen receptor modulator, binds to the androgen receptor with high affinity and selectivity. It demonstrates anabolic activity in muscles, anti-resorptive and anabolic activity in bones and a robust selectivity for muscle and bone versus prostate and sebaceous glands. LGD-4033 has recently completed a Phase I Multiple Ascending Dose study in healthy volunteers.  This randomized, double-blind, placebo-controlled Phase I study established the safety and tolerability up to doses of 22 mg per day.

Ligandrol(LGD-4033) Usages:
LGD is still fairly new (3-5 years), but the results have been very similar in studies and logs. LGD-4033 has undergone several recent studies and trials to find the best and safest way to use it. From these trials, the results have shown increases in lean body mass and decreases in body fat. There is also a significant increase in strength, well being, as well as healing possibilities.

Our company's website is http://www.hkdmk.com/
My WhatsApp:+8618942921723
E-mail:wzh@dmksw.xin
Skype:+8618942921723